title: A warning about agranulocytosis with the use of cocaine adulterated with levamisole.
abstract: Since 2004, the US Food And Drug Administration and the European Medicine Agency are giving warnings about cocaine adulterated with levamisole. Levamisole is primarily used as an anti-helminthic. One of the side-effects of levamisole is a decreased bone marrow function. Herein we describe the first case of agranulocytosis and neutropenic fever due to cocaine adulterated with levamisole reported in Europe.
authors.affiliation: Department of Haematology, Antwerp University Hospital, Edegem, Belgium. stany.perkisas@uza.be
authors.forename: S
authors.initials: S
authors.lastname: Perkisas
authors.forename: I
authors.initials: I
authors.lastname: Vrelust
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: A
authors.initials: A
authors.lastname: Gadisseur
authors.forename: W
authors.initials: W
authors.lastname: Schroyens
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced* / Q000276:immunology; D000969:Antinematodal Agents / Q000009:adverse effects; D003042:Cocaine / Q000737:chemistry; D019970:Cocaine-Related Disorders / Q000150:complications*; D004340:Drug Contamination; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007978:Levamisole / Q000009:adverse effects
chemical_list: D000969:Antinematodal Agents; D007978:Levamisole; D003042:Cocaine